Price $61.31 |
Market Cap
146.93B
|
Sector Health Care |
Div. Growth
9.30%
|
|
P/E
-
|
P/B
3.97
|
P/S
3.29
|
Dividend %
3.00%
|
|
P/CF
-
|
P/FCF
19.9
|
Op. Cash Flow
12.51M
|
FCF
3.2
|
|
Op. Margin
-15.70%
|
Net Margin
-11.40%
|
ROE
-12.50%
|
ROI
-12.10%
|
|
ROA
-4.30%
|
EPS Growth
-
|
Current Ratio
1.6
|
Debt/Equity
127.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cidara Therapeutics Inc (CDTX) | $2.13 | - | - | 107.4M | Strong Buy |
| Inogen Inc (INGN) | $49.25 | - | - | 1.36B | Strong Buy |
| Tempest Therapeutics Inc (TPST) | $15.12 | - | - | 99.7M | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $3.71 | - | - | 121M | Strong Buy |
| Endo International PLC (ENDP) | $2.83 | - | - | 499.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
